2 / 8
Volume 6 Issue 5(Suppl)
J Alzheimers Dis Parkinsonism 2016
ISSN:2161-0460 JADP, an open access journal
Page 14
Dementia 2016
September 29-October 01, 2016
conference
series
.com
September 29-October 01, 2016 London, UK
5
th
International Conference on
Alzheimer’s Disease & Dementia
Claude M Wischik, J Alzheimers Dis Parkinsonism 2016, 6:5(Suppl)
http://dx.doi.org/10.4172/2161-0460.C1.020Biography
Claude M Wischik holds the Chair in Old Age Psychiatry at the University of Aberdeen in Scotland, and is Executive Chairman of TauRx Pharmaceuticals. He
studied medicine in Australia, completed his PhD at the Laboratory of Molecular Biology in Cambridge, and also higher psychiatric training in Cambridge. He was
the first to identify Tau protein as the main constituent of the Alzheimer tangle and developed the first Tau Aggregation Inhibitors. He has published 121 papers and
holds 11 patent groups based on his work with over 40 individual patents.
cmw@taurx.comClaude M Wischik
TauRx Therapeutics, United Kingdom